NOD mice, susceptible to pancreatic autoimmunity, demonstrate delayed growth of pancreatic cancer.

Dooley, James; Pasciuto, Emanuela; Lagou, Vasiliki; Lampi, Yulia; Dresselaers, Tom; Himmelreich, Uwe; Liston, Adrian

Dooley, James; Pasciuto, Emanuela; Lagou, Vasiliki; Lampi, Yulia; Dresselaers, Tom; Himmelreich, Uwe; Liston, Adrian.

Afiliação

Dooley J; Translational Immunology Laboratory, VIB, Leuven, Belgium.
Pasciuto E; Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.
Lagou V; Translational Immunology Laboratory, VIB, Leuven, Belgium.
Lampi Y; Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.
Dresselaers T; Translational Immunology Laboratory, VIB, Leuven, Belgium.
Himmelreich U; Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.
Liston A; Translational Immunology Laboratory, VIB, Leuven, Belgium.

Oncotarget ; 8(46): 80167-80174, 2017 Oct 06.

Article em En | MEDLINE | ID: mdl-29113292

Palavras-chave

MRI; NOD; immune; pancreatic cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google